Literature DB >> 16036426

Rating the severity of ALS by caregivers over the telephone using the ALSFRS-R.

Edward J Kasarskis1, Linda Dempsey-Hall, Megan Malley Thompson, Lan Chi Luu, Marta Mendiondo, Richard Kryscio.   

Abstract

We tested the hypothesis that the ALSFRS-R can be accurately administered exclusively to the spouse/caregiver over the telephone (phone) in 31 patients with clinically possible, probable, or definite ALS (El Escorial criteria) by comparing the phone response to the consensus assessment during a clinic visit using a standardized script. We also compared the responses of the spouse/caregiver, during a private assessment, to the consensus assessment. Both the phone and private assessments were highly correlated with the consensus assessment, even considering that the evaluations were performed by multiple phone assessors and, in three instances, multiple home assessors. These results suggest the possibility of using this approach to conduct research in ALS.

Entities:  

Mesh:

Year:  2005        PMID: 16036426     DOI: 10.1080/14660820510027107

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord        ISSN: 1466-0822


  16 in total

1.  A cross-sectional analysis of clinical evaluation in 35 individuals with mutations of the valosin-containing protein gene.

Authors:  Jake Plewa; Abhilasha Surampalli; Marie Wencel; Merit Milad; Sandra Donkervoort; Vincent J Caiozzo; Namita Goyal; Tahseen Mozaffar; Virginia Kimonis
Journal:  Neuromuscul Disord       Date:  2018-06-27       Impact factor: 4.296

2.  Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial.

Authors:  Swati P Aggarwal; Lorne Zinman; Elizabeth Simpson; Jane McKinley; Katherine E Jackson; Hanika Pinto; Petra Kaufman; Robin A Conwit; David Schoenfeld; Jeremy Shefner; Merit Cudkowicz
Journal:  Lancet Neurol       Date:  2010-04-01       Impact factor: 44.182

3.  Age of onset differentially influences the progression of regional dysfunction in sporadic amyotrophic lateral sclerosis.

Authors:  Daichi Yokoi; Naoki Atsuta; Hazuki Watanabe; Ryoichi Nakamura; Akihiro Hirakawa; Mizuki Ito; Hirohisa Watanabe; Masahisa Katsuno; Yuishin Izumi; Mitsuya Morita; Akira Taniguchi; Masaya Oda; Koji Abe; Kouichi Mizoguchi; Osamu Kano; Satoshi Kuwabara; Ryuji Kaji; Gen Sobue
Journal:  J Neurol       Date:  2016-04-15       Impact factor: 4.849

4.  New considerations in the design of clinical trials for amyotrophic lateral sclerosis.

Authors:  James D Berry; Merit E Cudkowicz
Journal:  Clin Investig (Lond)       Date:  2011-10

5.  Heterogeneity in ALSFRS-R decline and survival: a population-based study in Italy.

Authors:  Jessica Mandrioli; Sara Biguzzi; Carlo Guidi; Elisabetta Sette; Emilio Terlizzi; Alessandro Ravasio; Mario Casmiro; Fabrizio Salvi; Rocco Liguori; Romana Rizzi; Vladimiro Pietrini; Annamaria Borghi; Rita Rinaldi; Nicola Fini; Elisabetta Chierici; Mario Santangelo; Enrico Granieri; Vittoria Mussuto; Silvia De Pasqua; Eleni Georgoulopoulou; Antonio Fasano; Salvatore Ferro; Roberto D'Alessandro
Journal:  Neurol Sci       Date:  2015-07-24       Impact factor: 3.307

Review 6.  Considerations for Amyotrophic Lateral Sclerosis (ALS) Clinical Trial Design.

Authors:  Christina N Fournier
Journal:  Neurotherapeutics       Date:  2022-07-11       Impact factor: 6.088

7.  Validation of the German version of the extended ALS functional rating scale as a patient-reported outcome measure.

Authors:  Susanne Abdulla; Stefan Vielhaber; Sonja Körner; Judith Machts; Hans-Jochen Heinze; Reinhard Dengler; Susanne Petri
Journal:  J Neurol       Date:  2013-06-05       Impact factor: 4.849

8.  Online assessment of ALS functional rating scale compares well to in-clinic evaluation: a prospective trial.

Authors:  André Maier; Teresa Holm; Paul Wicks; Laura Steinfurth; Peter Linke; Christoph Münch; Robert Meyer; Thomas Meyer
Journal:  Amyotroph Lateral Scler       Date:  2012-02

9.  Is dignity therapy feasible to enhance the end of life experience for people with motor neurone disease and their family carers?

Authors:  Brenda Bentley; Samar M Aoun; Moira O'Connor; Lauren J Breen; Harvey Max Chochinov
Journal:  BMC Palliat Care       Date:  2012-09-20       Impact factor: 3.234

10.  Feasibility, acceptability and potential effectiveness of dignity therapy for family carers of people with motor neurone disease.

Authors:  Brenda Bentley; Moira O'Connor; Lauren J Breen; Robert Kane
Journal:  BMC Palliat Care       Date:  2014-03-19       Impact factor: 3.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.